Regenerative Medical Technology Group Inc. earnings releases RMTG

Regenerative Medical Technology Group Inc. last reported quarterly results on May 21, 2025, for Q1 FY2025 (the quarter ended Mar 31, 2025): revenue of $1.4 million (+67.0% year over year) and diluted EPS of -$0.06. It usually reports 50–53 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 50–53 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
May 21, 2025
51 days after quarter end
Q1 FY2025
ended Mar 31, 2025
1
+67.0%
-1
+61.2%
-0.06
+62.5%
Nov 19, 2024
50 days after quarter end
Q2 FY2024
ended Sep 30, 2024
—
—
—
May 23, 2024
53 days after quarter end
Q1 FY2024
ended Mar 31, 2024
1
+3.9%
-2
-17.4%
-0.16
-23.1%

Company profile

Industry
Retail-Retail Stores, NEC (SIC 5990)
Listed as
RMTG (OTC)
Fiscal year ends
December 31
Headquarters
Boca Raton, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1760026
Former names
MESO NUMISMATICS, INC. (until Oct 24, 2024)

Other Retail-Retail Stores, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.